Aiforia signs commercial agreement with PathAI to list AI diagnostics on AISight Marketplace

• Aiforia struck a commercial agreement with PathAI to distribute its AI pathology tools via the AISight Dx Marketplace.
• Deal extends Aiforia’s CE-IVD-marked models beyond Europe, tapping PathAI’s installed base to expand reach in the U.S.
• Algorithms will integrate into AISight Dx case-review workflows, with contracting, billing, and support handled through PathAI’s platform.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aiforia Technologies Oyj published the original content used to generate this news brief on October 08, 2026, and is solely responsible for the information contained therein.